Clinical Report: Why One Number Isn’t Enough for Patients

Overview

Effective communication of risk in clinical settings requires presenting numerical data with meaningful comparisons. This approach enhances patient understanding and decision-making regarding their health risks and treatment options.

Background

The interpretation of risk numbers is crucial in clinical practice, as patients often struggle to understand isolated statistics. Providing context through comparisons can significantly alter patients' perceptions and decisions. This topic is particularly relevant in shared decision-making, where informed patient choices are essential for optimal care.

Data Highlights

Key Findings

• Patients find risk numbers more interpretable when provided with comparative data.
• Research indicates that women are more likely to consider taking medication when their risk is presented as higher than average.
• Without comparative data, perceptions of treatment effectiveness can be inflated.
• Two numbers can transform abstract statistics into actionable information for patients.
• Guidelines recommend presenting both relative and absolute effects to avoid exaggerating perceived benefits.

Clinical Implications

Clinicians should incorporate comparative risk data when discussing health risks with patients to enhance understanding and facilitate informed decision-making. This practice aligns with current guidelines emphasizing the importance of context in risk communication.

Conclusion

Incorporating comparative statistics into patient discussions can significantly improve understanding and decision-making. This approach is essential for effective patient-centered care.

Related Resources & Content

1. Peters E, Jennings NS, JAMA, 2026 -- Using Numerical Comparisons to Help Patients Make Choices
2. Brennan MF, The ASCO Post, 2019 -- Databases: Where Math Meets Medicine
3. The ASCO Post, 2013 -- Consent Is Informed and Shared, But Is It Compassionate?
4. The ASCO Post, 2013 -- Innovative Payment Models Needed to Sustain Quality Cancer Care
5. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials, The BMJ, 2024
6. Optometric Management — view from the top - Why O.D.s don't sell more eyeglasses.
7. Using Numerical Comparisons to Help Patients Make Choices | Shared Decision Making and Communication | JAMA | JAMA Network
8. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials | The BMJ
9. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/CD/lipids/Lipids-CPG_2025-Guideline_final_20260106.pdf